Jeffrey Barrett
Hoofd Techniek/Wetenschap/O&O bij NIGHTINGALE HEALTH OYJ
Vermogen: 15 708 $ op 31-05-2024
Profiel
Jeffrey Barrett is currently the Chief Scientific Officer at Nightingale Health Oyj since 2021.
Prior to this, he worked as the Director and Chief Scientific Officer at Genomics Plc.
He obtained a doctorate degree from the University of Oxford.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 8 364 ( 0.02% ) | 15 708 $ | 31-05-2024 |
Actieve functies van Jeffrey Barrett
| Bedrijven | Functie | Begin |
|---|---|---|
| NIGHTINGALE HEALTH OYJ | Hoofd Techniek/Wetenschap/O&O | 27-09-2021 |
Eerdere bekende functies van Jeffrey Barrett
| Bedrijven | Functie | Einde |
|---|---|---|
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jeffrey Barrett
| University of Oxford | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NIGHTINGALE HEALTH OYJ | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
